Benjamin Kelmendi

Benjamin Kelmendi, M.D., is an Associate Research Scientist at Yale University School of Medicine, Department of Psychiatry. Dr. Kelmendi’s research explores the mechanism of symptoms that characterize obsessive-compulsive disorder and post-traumatic stress disorder, with the ultimate goal of developing new understandings and better treatments. In parallel, he is interested in elucidating the neurobiological mechanisms of pharmacological interventions that produce acute clinical effects such as MDMA, psilocybin, and ketamine using various methodological tools including fMRI, MRS, EEG, genetics, and neurocognitive testing. Dr. Kelmendi received his medical degree from the University of Vermont College of Medicine.